FDA Investigator Babajide Michael Osunsanmi
Babajide Michael Osunsanmi has inspections in 1 countries as of 06 Nov 2023. Babajide Michael Osunsanmi has collaborated with a combinined 2706 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
38
Last Inspection Date:
06 Nov 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Abby M Miller,
Ademola O Daramola,
Alan L Truong,
Alan P Kurtzberg,
Albert C Cheng,
Alexandra B Pitkin,
Allison A Rodriguez,
Amalia C Himaya,
Amir Alavi,
Angelina M Albert,
Anita Narula, PhD,
April P Shaw,
Arsen Karapetyan,
Barbara J Rincon,
Belinda E Clifton,
Binh T Nguyen,
Bowman,
Brian J Ryan,
Brian P Putz,
Brien C Fox,
Bryan A Galvez,
Bryce A Hammer,
Bush,
Candace Y Gomez Broughton,
Carla J Lundi,
Carol B Czerniak,
Carr Sharpe,
Caryn M Everly,
Caryn M Mcnab,
Cecilia H Kieu,
Celena Ngo,
Chelsea N Sealey,
Crystal Monroy,
Darren S Brown,
David G Whitman,
David Y Hernandez,
Davis,
Deborah A Greco,
Deborah G Park,
Dejon N Harris,
Diane Cvan Leeuwen,
Doan T Nguyen, PharmD,
Donna Ltartaglino Besone,
Donna Mwilliams Hill,
Dyana K Stone,
Esther B Gamallo Herrera,
Garciam,
Gavin T Cua,
Geraldine M Peregrin,
Grace P Santos,
Greg K Keshishyan,
Guillermo,
Henry E Carrillo,
Hoover,
Jacob W Reynolds,
Jacobitz,
Jacqueline C Sram,
James A Barreto,
Jane S Wernberg,
Jasmine N Thompson,
Jeff M Uriarte,
Jeffery A Johnson,
Jeffrey P Raimondi,
Jennifer M Gogley,
Jeremy Beber,
Jeremy H Nguyen,
Joel D Hustedt,
Joey V Quitania,
John A Gonzalez,
John P Jorgensen,
Jolanna A Norton,
Joseph C Yen,
Judy C Nepsa,
Julie A Rorberg,
Julie A Stocklin,
Julie Rorberg,
Ka L Wong,
Katherine E Jacobitz,
Kawshalya Pathiraja,
Kelley,
Kevin Lee,
Kham Phommachanh,
Khoa Nathanv Tran,
Kim Lthomas Cruse,
Kirtida Patel,
Langer,
Lanita F Kelley,
Leonard H Lavi,
Linda Thai,
Linda Than,
Ling Yul Liu,
Lisa Shin,
Louis B Cencetti,
Marco S Esteves,
Marcus F Yambot,
Mark C Saale,
Matthew J Johnson,
Michael D Garcia,
Michael F Schuette,
Michael S Call,
Michael Shanks, MS,
Minh D Phan,
Myers,
Nancy E Byerly,
Natalie J Ayoub,
Nianna C Burns,
Nicholas L Hunt,
Patricia F Alberico,
Paul A Bonneau,
Paul R Whitby,
Phal K Chhun,
Phillip L Toy,
Rachel C Stanton,
Richard C Chiang,
Richard W Tubb,
Richmond K Yip,
Robert C Hoover,
Rochelle A Rolnik,
Rocio Guzman Velazquez,
Rowena S Nguyen,
Rumany C Penn, PharmD,
Saied A Asbagh,
Santiago Gallardo Johnson,
Scott J Matsuda,
Sean P Desbrow,
Selene T Torres,
Sharon S Ho,
Sonia R Peterson,
Sonya L Karsik,
Sparky L Bartee,
State Agency,
Stephanie A Slater, MS,
Sundy V Sedwick,
Sundy Ven,
Taichun Qin, PhD,
Tamala P Bogan,
Tamala P Magee,
Tamara L Ely,
Tammy Vasquez Hancock,
Tara L Stockton,
Terrance P Nguyen,
Terri L Dodds,
Thao T Kwan,
That T Kwan,
Theresa Kirkham (NMI),
Thomas J Arista,
Thomas R Beilke,
Thuy T Nguyen, LCDR,
Tracey T Duong,
Truong Xuan Nguyen (Andy),
Uttaniti Limchumroon (Tom),
Uttaniti Lischumroon,
Vashti E Bocker,
Vickie L Anderson,
Virgilio F Pacio, CSO,
William D Boden,
Yasamin Ameri,
Yvette Mlacour Davis,
Yvonne T Lacour,
Zachary A Bogorad,
Zachary L Miller
Babajide Michael Osunsanmi's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| June, 2009 | FDA 483 | Thibiant International, Inc. - Form 483, 2009-06-25 |
| February, 2011 | FDA 483 | Private Label Partners, Inc. - Form 483, 2011-02-10 |
| March, 2010 | FDA 483 | PRESTIGE COSMETICS, INC. - Form 483, 2010-03-24 |
| December, 2009 | FDA 483 | Preferred Pharmaceuticals Inc. - Form 483, 2009-12-30 |
| May, 2010 | FDA 483 | Old Fashioned Natural Products Inc - Form 483, 2010-05-27 |
| April, 2010 | FDA 483 | 220 Laboratories LLC. - Form 483, 2010-04-26 |
| February, 2010 | FDA 483 | MeriCal, Inc - Form 483, 2010-02-10 |
| August, 2010 | FDA 483 | Beauty Health & Science Innovations Inc - Form 483, 2010-08-25 |
| August, 2010 | FDA 483 | Almil Nutritional Products, Inc. - Form 483, 2010-08-09 |
| January, 2010 | FDA 483 | GMP Laboratories of America Inc - Form 483, 2010-01-20 |
| July, 2009 | FDA 483 | Pacira Pharmaceuticals, Inc. - Form 483, 2009-07-10 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more